Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its origins, including bone marrow, cord blood, or peripheral blood. By using the novel technology, we are developing a cell therapy product that brings HSC transplantation to the next level and helps patients with blood disorders. Our technology has many potential applications including gene/cell therapy that utilize gene editing on HSC. Our mission is to improve QOL of patients, their families, and HSC donors all over the world.
View Top Employees from Celaid TherapeuticsWebsite | https://celaidtx.com/ |
Employees | 12 (6 on RocketReach) |
Founded | 2020 |
Industry | Biotechnology |
Looking for a particular Celaid Therapeutics employee's phone or email?
Motoo Watanabe is the Chairman and Chief Scientific Officer of Celaid Therapeutics.
6 people are employed at Celaid Therapeutics.